This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Asantae Releases New White Paper On RealW8™

In TO770 disseminated today at 09:19e, please note that both hyperlinks in the fifth paragraph have been corrected. Corrected copy follows:

Asantae Releases New White Paper on RealW8™

VANCOUVER, March 13, 2012 /PRNewswire/ - Asantae Holdings International Inc. (TSXV: JVA) (OTC PINK: ASNHF) ("Asantae" or the "Company"), a producer and marketer of innovative nutritional products through a network of independent distributors, has released a new white paper on its flagship product, RealW8™.

In a recent interview on Fox and Friends, Dr. Dwight Lundell, formulator of RealW8™, discusses with Gretchen Carlson, how over-consumption of dietary carbohydrates (simple carbohydrates and sugars) affect heart disease.  This white paper addresses how RealW8™, by moderating blood sugar spikes caused by dietary carbohydrates, can help individuals lose weight.

"RealW8™ is an extraordinary product that provides real solutions to the obesity epidemic," says Asantae's CEO, Dan Lundell.  He further stated, "The evidence is clear that the obesity is caused by over-consumption of dietary carbohydrates.  RealW8™ addresses obesity in a unique way by allowing us to break our addiction to dietary carbohydrates."

"This document discusses, 1) Why dietary carbohydrates are the root cause of obesity; 2) Why we are addicted to dietary carbohydrates; and, 3) How RealW8™ addresses the addiction and helps us lose weight."

The RealW8™ white paper can be found at (choose 'save', or 'save as') and the Fox News interview with Dr. Lundell can be found

About Asantae

Asantae Holdings International Inc. ( is a producer and marketer of innovative nutritional products through a network of independent distributors (Asantae Independent Affiliates). Asantae's flagship product RealW8™ addresses the primary threat to public health in the industrialized world; overweight and obesity.  Asantae's approach to this threat is based on a body of research related to the brain chemistry of addiction, chronic low-grade inflammation and oxidative stresses which, according to scientific and medical research, are the underlying conditions for most modern epidemic diseases (obesity, heart disease, diabetes, stroke, some cancers, etc.).

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs